Insulin delivery devices that are currently available for the administration of insulin include syringes, insulin infusion pumps, jet injectors and pens.

The global Insulin Drug Delivery Devices market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Insulin Drug Delivery Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Insulin Drug Delivery Devices market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Novo Nordisk
Sanofi
BD
Eli Lilly
Medtronic
Beta Bionics
Dance Biopharm
Roche
Tandem Diabetes Care
Animas

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Syringes
Insulin Pens
Jet Injectors
Insulin Pumps

Segment by Application
Hospitals
Clinics
Homecare
Others